Heterogeneous Nuclear Ribonucleoprotein C is an Indispensable Target in Acute Myeloid Leukemia
V. Vijay, A. Meacham, L. M. Katzell, A. J. Winer, J. Terrell, V. L. Archibald, L. T. Vaughn, L. Drusbosky, E. Thach, G. Welmaker, M. Giulianotti, S. Brothers, E. Beurel, J. L. Bubenik, M. Swanson, , C. R. Cogle
This study identifies HNRNPC as a critical therapeutic target in AML by showing its role in regulating Myc-Max activity through alternative splicing.
bioRxiv · Oct 2, 2023 · PreprintCancer Biology